Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-04

Clinical Trial Update: The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on PRN Omega-3 Nutritional Supplement assessing visual acuity in cataract and dry eye disease during Phase 2 and Phase 3. The sponsor is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRN Omega-3 Nutritional Supplement (Omega-3 fatty acids supplement)

Snippet

Sponsor: Physician Recommended Nutriceuticals | Conditions: Cataract, Dry Eye Disease | Phase 2, Phase 3 | Status: UNKNOWN